Justin Cahill
About Justin Cahill
Justin Cahill serves as the Chief Financial Officer at Starpharma, bringing extensive experience in finance leadership across various industries. His career includes significant roles at companies such as CSL Plasma, Diver Foods Pty Ltd, and Paradigm Biopharmaceuticals, where he developed expertise in risk management, strategic planning, and M&A integration.
Current Role at Starpharma
Justin Cahill serves as the Chief Financial Officer at Starpharma, a position he has held since 2023. He is based in Abbotsford, Victoria, Australia, and works on-site. In this role, he is responsible for overseeing the financial operations of the company, contributing to its strategic financial planning and management.
Previous Experience in Finance
Prior to his current role, Justin held several key financial positions. He worked as Chief Financial Officer at Paradigm Biopharmaceuticals from 2020 to 2023. Before that, he served as Chief Financial Officer at Diver Foods Pty Ltd from 2018 to 2020 and as Divisional CFO at CSL Plasma from 2011 to 2015. His experience spans various sectors, including FMCG, pharmaceutical, and biotech.
Educational Background
Justin studied at Swinburne University of Technology, where he earned a Master's degree in Accounting from 2003 to 2005. He also completed a Bachelor of Business degree with a focus on Accounting and Marketing from 1996 to 1998. Additionally, he has professional qualifications from CPA, enhancing his expertise in finance.
Expertise in Financial Management
Justin possesses extensive experience in managing finance functions across multiple industries, including FMCG, pharmaceutical, biotech, and agriculture. He has developed strong skills in risk management, treasury, and investor relations. His strategic finance leadership capabilities are complemented by his expertise in strategic planning and M&A integration.
Career Progression and Roles
Throughout his career, Justin has held various significant roles. He worked as a Financial Accounting Manager at SCA Hygiene Australasia from 2004 to 2007, and as a Group Finance Manager at Costa from 2017 to 2018. His tenure at CSL included positions such as Sr Director Corporate Finance and Divisional Controller for CSL Biotherapies, showcasing his progressive career in finance.